参考文献/References:
[1]Schoenfeld SR,Kasturi S,Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE:a systematic review[J]. Semin Arthritis Rheum,2013,43(1):77-95.
[2]Benjamin EJ,Virani SS,Callaway CW,et al. Heart disease and stroke statistics-2018 update:a report from the American heart association[J]. Circulation,2018,137(12):e67-e492.
[3]Kim CH,Al-Kindi SG,Jandali B,et al. Incidence and risk of heart failure in systemic lupus erythematosus[J]. Heart,2017,103(3):227-233.
[4]Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus[J]. Arthritis and rheumatism,1999,42(2):338-346.
[5]Bartels CM,Buhr KA,Goldberg JW,et al. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort[J]. J Rheumatol,2014,41(4):680-687.
[6]Bahrami H,Kronmal R,Bluemke DA,et al. Differences in the incidence of congestive heart failure by ethnicity:the multi-ethnic study of atherosclerosis[J]. Arch Intern Med,2008,168(19):2138-2145.
[7]Apte M,McGwin G, Vilá LM ,et al. Associated factors and impact of myocarditis in patients with SLE from LUMINA,a multiethnic US cohort(LV)[J]. Rheumatology (Oxford),2008,47(3):362-367.
[8]Dhakal BP,Kim CH,Al-Kindi SG,et al. Heart failure in systemic lupus erythematosus[J]. Trends Cardiovasc Med,2018,28(3):187-197.
[9]任昊,许顶立. 系统性红斑狼疮合并心力衰竭研究进展[J]. 中国实用内科杂志,2018,38(8):762-765.
[10]张翠,蔡琳,汪汉. 结缔组织病与心力衰竭[J]. 心血管病学进展,2018,39 (4):677-681.
[11]Pons-Estel GJ,González LA,, Zhang J,et al. Predictors of cardiovascular damage in patients with systemic lupus erythematosus:data from LUMINA (LXVIII),a multiethnic US cohort[J]. Rheumatology (Oxford),2009,48(7):817-822.
[12]Liu C,Wei Y,Wang J,et al. Carbonic anhydrasesⅢandⅣautoantibodies in rheumatoid arthritis,systemic lupus erythematosus,diabetes,hypertensive renal disease,and heart failure[J]. Clin Dev Immunol,2012,2012:354594.
[13]de Godoy MF,Oliveira CMD,Fabri VA,et al. Long-term cardiac changes in patients with systemic lupus erythematosus[J]. BMC Res Notes,2013,6:171.
[14]Mandell BF. Cardiovascular involvement in systemic lupus erythematosus[J]. Semin Arthritis Rheum,1987,17(2):126-141.
[15]Comarmond C,Cacoub P. Myocarditis in auto-immune or auto-inflammatory diseases[J]. Autoimmun Rev,2017,16(8):811-816.
[16]Moyssakis I,Tektonidou MG,Vasilliou VA,et al. Libman-Sacks endocarditis in systemic lupus erythematosus:prevalence,associations,and evolution[J]. Am J Med,2007,120(7):636-642.
[17]Karp I,Abrahamowicz M,Fortin PR,et al. Recent corticosteroid use and recent disease activity:independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?[J]. Arthritis Rheum,2008,59(2):169-175.
[18]Tsukamoto H,Nagafuji K,Horiuchi T,et al. A phaseⅠ-Ⅱtrial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease[J]. Ann Rheum Dis,2006,65(4):508-514.
[19]Onuora S. Systemic lupus erythematosus:Rituximab improves SLE disease activity[J]. Nat Rev Rheumatol,2018,14(2):62.
[20]Mavrogeni S,Koutsogeorgopoulou L,Dimitroulas T,et al. Complementary role of cardiovascular imaging and laboratory indices in early detection of cardiovascular disease in systemic lupus erythematosus[J]. Lupus,2017,26(3):227-236.
[21]Urowitz MB,Gladman D,Ibanez D,et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus[J]. Arthritis Care Res (Hoboken),2010,62(6):881-887.
[22]Fernández-Nebro A,Rúa-Figueroa ?,López-Longo FJ,et al. Cardiovascular events in systemic lupus erythematosus:A nationwide study in Spain from the RELESSER registry[J]. Medicine (Baltimore),2015,94(29):e1183.
[23]Hermansen ML,Lindhardsen J,Torp-Pedersen C,et al. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis:a Danish nationwide population-based cohort study[J]. Rheumatology (Oxford),2017,56(5):709-715.
[24]Bruce IN,Urowitz MB,Gladman DD,et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus:the Toronto risk factor study[J]. Arthritis Rheum,2003,48(11):3159-3167.
[25]Haque S,Gordon C,Isenberg D,et al. Risk factors for clinical coronary heart disease in systemic lupus erythematosus:the lupus and atherosclerosis evaluation of risk (LASER) study[J]. J Rheumatol,2010,37(2):322-329.
[26]Munguia-Realpozo P,Mendoza-Pinto C,Sierra Benito C,et al. Systemic lupus erythematosus and hypertension[J]. Autoimmun Rev,2019,18(10):102371.
[27]Kannel WB,Hjortland M,Castelli WP. Role of diabetes in congestive heart failure:the Framingham study[J]. Am J Cardiol,1974,34(1):29-34.
[28]Roman MJ,Shanker BA,Davis A,et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus[J]. N Engl J Med,2003,349(25):2399-2406.
[29]Sada KE,Yamasaki Y,Maruyama M,et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus[J]. J Rheumatol,2006,33(8):1545-1552.
[30]Roldan CA,Shively BK,Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus[J]. N Engl J Med,1996,335(19):1424-1430.
相似文献/References:
[1]赵诚,综述,朱丹,等.甲状旁腺功能减退与心脏损害[J].心血管病学进展,2016,(2):133.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.009]
ZHAO Cheng,ZHU Dan.Hypoparathyroid and Cardiac Damage[J].Advances in Cardiovascular Diseases,2016,(4):133.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.009]
[2]王振,综述,惠杰,等.迷走神经刺激与心力衰竭[J].心血管病学进展,2016,(2):197.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.026]
WANG Zhen,HUI Jie.Vagus Nerve Stimulation and Heart Failure[J].Advances in Cardiovascular Diseases,2016,(4):197.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.026]
[3]陈焕,综述,邓平,等.S100A1蛋白基因治疗心力衰竭的研究进展[J].心血管病学进展,2016,(3):302.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.023]
CHEN Huan,DENG Ping.Research Progress in S100A1 Gene Therapy for Heart Failure[J].Advances in Cardiovascular Diseases,2016,(4):302.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.023]
[4]唐毅,柳志红,黄智伟,等.运动振荡呼吸在心力衰竭中的应用[J].心血管病学进展,2015,(5):551.[doi:10.3969/j.issn.1004-3934.2015.05.007]
TANG Yi,LIU Zhihong,HUANG Zhiwei,et al.Application of Exercise Oscillatory Ventilation in Heart Failure[J].Advances in Cardiovascular Diseases,2015,(4):551.[doi:10.3969/j.issn.1004-3934.2015.05.007]
[5]梅宝菲,孔一慧,李为民.睡眠障碍与心血管疾病研究新进展[J].心血管病学进展,2015,(5):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
MEI Baofei,KONG Yihui,LI Weimin.Relationship Between Somnipathy and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(4):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
[6]唐光能,洪炳哲.Junctate蛋白在心力衰竭中的研究进展[J].心血管病学进展,2015,(5):629.[doi:10.3969/j.issn.1004-3934.2015.05.028]
TANG Guangneng,HONG Bingzhe.Research Development of Junctate Protein in Heart Failure[J].Advances in Cardiovascular Diseases,2015,(4):629.[doi:10.3969/j.issn.1004-3934.2015.05.028]
[7]姜琳,袁晋青.缺血性心肌病的血运重建治疗[J].心血管病学进展,2015,(6):677.[doi:10.3969/j.issn.1004-3934.2015.06.006]
JIANG Lin,YUAN Jinqing.Revascularization in Ischemic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(4):677.[doi:10.3969/j.issn.1004-3934.2015.06.006]
[8]崔圆,孙宏超,侯维娜,等.生长分化因子15与心力衰竭的相关研究进展[J].心血管病学进展,2015,(6):759.[doi:10.3969/j.issn.1004-3934.2015.06.026]
CUI Yuan,SUN Hongchao,HOU Weina,et al.Research Progress on Growth Differentiation Factor-15 Associated with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(4):759.[doi:10.3969/j.issn.1004-3934.2015.06.026]
[9]徐学萍 汪汉 蔡琳.结缔组织病相关心脏瓣膜病[J].心血管病学进展,2019,(9):1267.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.021]
XU Xueping,WANG Han,CAI Lin.Connective Tissue Disease-associated Valvular Heart Disease[J].Advances in Cardiovascular Diseases,2019,(4):1267.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.021]
[10]秦莉,张艺文,杨晓倩,等.系统性红斑狼疮合并心力衰竭的危险因素及管理[J].心血管病学进展,2020,(3):264.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.012]
QIN Li,ZHANG Yiwen,YANG Xiaoqian,et al.Risk Factors and Management of Heart Failure in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2020,(4):264.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.012]